Neuro-Bio is extremely grateful for the kind donation from Nizami Ganjavi International Center of €14,000. Nizami Ganjavi International Center is a cultural, non-political organization dedicated to the memory of great Azerbaijani poet, Nizami...
In collaboration with The Rosalind Franklin Institute, we have been detecting a tiny peptide that could diagnose Alzheimer’s disease at an early stage, an SME focusing on therapeutics for neurodegenerative disease. Together, we were able to use our Mass Spectrometry...
Neuro-Bio’s CSO, Sara Garcia-Rates was excited to visit the university and be a part of the panel of the careers event, where she shared her experience of her career development and insight of the bio-tech industry. The panel was then followed by a...
Why do we celebrate this? – To inspire and engage others to pursue science, technology, engineering, and mathematics – To improve gender equality in science – To highlight the role of women and girls in science and technology communities – To...
In this fascinating Presentation, Baroness Greenfield delved into how we cope with the challenges of living longer and better in our lives, and why each and every one of us is unique. To watch the full Presentation, click here...
Our latest study, published in Neurobiology of Aging, investigates the role of the novel peptide T14 in age-dependent behaviours using female mice models. The findings highlight significant variations in T14 levels with age, shedding light on potential mechanisms...
Their final episode of season two rounded out the theme of prevention by focusing on an area of significant impact for many of us personally and professionally. Baroness Susan Greenfield (Neuro-Bio Ltd) spoke about and explored the possibilities for preventing...
“In six months we will have the test for Alzheimer’s, and in two months, the cure!” Baroness Greenfield talks about Alzheimer’s Disease, and the focus on discovering a test and a cure! To read the full interview, with the option to translate,...
BLOWING THE MIND, EXPANDING THE MIND & LOSING THE MIND The human brain becomes highly personalized after birth by the development of unique configurations of connections between the brain cells that characterize its subsequent growth, personalizing it into what we...
Our study demonstrates that T14, a 14-mer peptide associated with Alzheimer’s disease, impairs autophagy via the mammalian target of rapamycin complex 1, contributing to the progression of the pathology. This finding adds a new layer of understanding to how T14...
